MLchartDataset catalogue

Copanlisib hydrochloride

Term · Oncology and biomedicine · MLC-T-ONC-012730

The dihydrochloride salt form of copanlisib, a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.

Table 1. Record
IdentifierMLC-T-ONC-012730
FieldOncology and biomedicine
Synonymscopanlisib dihydrochloride; BAY-80-6946 dihydrochloride
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012730",
  "term": "Copanlisib hydrochloride",
  "field": "Oncology and biomedicine",
  "definition": "The dihydrochloride salt form of copanlisib, a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.",
  "synonyms": [
    "copanlisib dihydrochloride",
    "BAY-80-6946 dihydrochloride"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/copanlisib-hydrochloride/"
}

Record 5,266 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.